AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L. have signed two strategic distribution agreements, which will enable Warba Medical Supplies to distribute the MosaiQ® and LumiQ® solutions in Kuwait. The distribution agreements take effect immediately.
This partnership underscores AliveDx’s dedication to broadening its global footprint and delivering clinical and economic value to clinicians, aiding in faster diagnosis. This collaboration will allow both parties to launch new quality services in the healthcare industry and improve patient care in Kuwait.
These agreements mark a significant step in AliveDx’s continued commitment to expanding its footprint in the Middle East and supporting healthcare providers with cutting-edge diagnostic solutions. Through this collaboration, AliveDx aims to deliver both clinical and economic value to clinicians by accelerating time to diagnosis and enhancing patient outcomes.
The MosaiQ and LumiQ platforms are designed to simplify laboratory workflows and enhance operational efficiency through fully automated, multiplex microarray assay technology. These platforms provide faster and more cost-effective diagnostic solutions, ultimately benefiting both healthcare providers and patients.
“This is another great opportunity to highlight AliveDx’s dedication to transforming patient care worldwide and strengthening the healthcare system with fast and innovative diagnostic solutions,” said Manuel O. Méndez, AliveDx’s CEO.
Established in 1978, Warba Medical Supplies Company is a leading distributor for pharmaceutical, medical and diagnostic solutions in Kuwait, and is known for its wide base of satisfied customers and excellent after sales technical and application support. Warba continues to pioneer the introduction of cutting-edge medical technologies to both the Ministry of Health and the private sector, enhancing diagnostics and healthcare services across Kuwait.
“We are honored to collaborate with AliveDx, we believe this partnership will complement our comprehensive specialised diagnostics portfolio. With our growing presence in the immunology diagnostics market, the addition of AliveDx solutions will further enhance our offerings in this important segment. We are confident that the MosaiQ and LumiQ technologies will bring best-in-class innovations to the diagnosis of autoimmune and allergy conditions, ultimately improving patient care in Kuwait,” said Hussam Saleh, Medical Division General Director at Warba Medical Supplies.
To learn more, please visit the Warba Medical Supplies website.
